Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relative Bioavailability of PF-06651600 Capsule Formulations vs Tablets in Healthy Participants
NCT04004663Phase 1Completed
- Sponsor
- Pfizer
- Start
- Jul 2019
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ritlecitinib tosilate in alopecia areata (4 arms), sponsored by Pfizer. Primary endpoints: Area under the plasma concentration-time profile from time zero extrapolated to infinite time at Day 2 and Maximum plasma concentration at Day 2. Started Jul 2019; status: completed.
02
Drugs
ritlecitinib tosilate
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT04004663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04004663.